Abstract
Controlled drug release refers to the technique of drug administration whereby a reservoir delivers drug to a host. Such a system releases the required drug at some rate for a predetermined period of time. The origins of controlled drug release can be traced as far back as 1000 yr ago. Rhazes (850–923) recommended mucilage coating of pills using an extract ofpsyllium, and Avicenna (980–1037) recommended silvering and gilding pills (1). The silvering and gilding technology found its way to Europe, where the nobility enjoyed the luxury of pills coated with silver or gold. Although the coatings served primarily to mask the taste of the bitter tasting agents, they nevertheless altered the release kinetics of the drugs they enveloped.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Sonnedecker G and Griffenhagen G. Sugarcoating the pill: a historical perspective. Pharm Tech 1980; 4: 77.
Langer RS and Wise DL. Medical Applications ofControlled Release, vol 1, 1984; CRC, Boca Raton, FL.
Cowser DR. Introduction to Controlled Release. Southern Research, Birmingham, AL.
Hsieh DS. Controlled Release Systems: Fabrication Technology, vol 2, 1988; CRC, Boca Raton, FL.
Miller RA, Brady JM, and Cutright DE. Degradation rates of oral resorbable implants (polylactates and polyglycolates): rate modification and changes in PLA/PGA copolymer ratios. J Biomed Mater Res 1977; 11: 711.
Gurny R, Junginger HE, and Peppas NA. Pulsatile Drug Delivery Current Applications and Future Trends, 1993; Wissenschaftliche Verlagsgesellschaft mBH, Germany.
Wise DL. Biopolymeric Controlled Release Systems, vol 1, 1984; CRC, Boca Raton, FL.
Ferencik M. Handbook oflmmunochemistry,1993; Chapman and Hall, London, p 117.
Kimball JW. Introduction to Immunology,2nd ed, 1986; MacMillan, New York.
Schmidt-GallwitzerM. LH-RHandltsAnaloguesFertility and Antifertility Aspects,1985; Walter de Gruyter, pp 2–3.
Jimoh AG, Wise DL, Gresser JD, Foote RH, Rhodes RC, and Trantolo DJ. Pulsatile release of follicle stimulating hormone. J Controlled Rel.
Jimoh AG, Wise DL, Gresser JD, Foote RH, Rhodes RC, and Trantolo DJ. Pulsatile release of FSH for cattle reproduction management. Theriogenology, 1995; 43: 645–656.
Greene L, Phan LX, Schmitt EE, and Muhr JM. Side-chain crystallizable polymers for temperature-activated controlled release, in Polymeric Delivery Systems: Properties and Applications, 1993; (Al-Nokaly MA, Charpentier BA, and Piatt DM, eds ), ACS Symposium Series 520.
Theeuwes F. Elementary osmotic pump. JPharma Sci 1975; 64: 12.
Ueda et al. US Patent 4,871,549, October 3, 1989.
Cohen S, Yoshioka T, Luconelli M, Hwang LH, and Langer RS. Controlled delivery systems for proteins based on poly(lactic/glycolic) acid micro-spheres. Pharm Res 1991; 8: 6.
Heller J. Chemically self-regulated drug delivery systems. J Controlled Rel 1988; 8: 111–125.
Brownlee M and Cerami A. A glucose-controlled insulin-delivery system: semisynthetic insulin bound to lectin. Science 1979; 206: 1190, 1191.
Brownlee M and Cerami A. Glycosylated insulin compound to Concanvalin A. Biochemical basis for a closed-loop insulin delivery system. Diabetes 1983; 32: 499–504.
Heller J, Pangburn SH, and Penhale DWH. Use of bioerodible polymers in self-regulated systems, in Controlled Release Technology, 1987; (Lee PI and Good WR, eds), ACS Symposium Series, No. 348, American Chemical Society, Washington DC, pp 172–187.
Heller J, Penhale DWH, and Pangburn SH. Chemically self-regulated drug delivery systems, in Polymers in Medicine, 1988; (Migliaresi C, Nicolais L, Giusti P, and Chiellini E, eds), Elsevier, Amsterdam, pp 175–188.
Herbert TA, Kost J, and Ratner BD. Swelling behaviour of glucose sensitive membranes, in Polymers as Biomaterials, 1984; (Shelaby SW, Hoffman AS, Ratner BD, and Herbert TA, eds), Plenum, New York, pp 193–207.
Ishihara K, Kobayashi M, and Shionohara I. Control of insulin permeation through a polymer membrane with responsive function for glucose, 1983; Makromol Chem 1983; 4: 327–331.
Ishihara K, Kobayashi M, and Shinihara I. Insulin permeation through amphihilic polymer membranes having 2-hydroxyethyl methacrylate moiety. Polym J 1984; 16: 647–651.
Miyazaki S, How W-M, and Takeda M. Controlled release by ultrasound irradiation. Chem Pharm Bull 1985; 33 (1): 428–431.
Edelman EK, Kost J, Bobeck H, and Langer RS. Regulation of drug release from polymer matrices by oscillating magnetic fields I. JBiomed Res 1985; 19: 67–83.
Kwan IC, Bae YH, and Kim SW. Heparin release from polymer complex. JControlled Rel 1994; 30: 155–159.
Ansel HC. Introduction to Pharmaceutical Dosage Forms 1985; Lea and Febiger, Philadelphia.
Brown P. Malaria vacccine passes key test. New Sci 1994; 7.
Redfern M. First trials for malaria vaccine. New Sci 1988.
TDR News. UNDP/World Bank/Who Special Program for Research and Training in Tropical Diseases (TDR), no 41, 1992.
TDR News. UNDP/World Bank/Who Special Program for Research and Training in Tropical Diseases (TDR), no 42, 1993
Strategic Plan forApplied Field Research in Tropical Diseases. UNDP/World Bank/Who Special Program for Research and Training in Tropical Diseases (TDR) and Division for Control of Tropical Diseases, World Health Organization (WHO).
Press release, WHO/13, Feb 13, 1994.
Kenley RA, Lee MO, Mahoney R, and Sanders LM. Poly(lactide-co-glycolide) decomposition kinetics in vivo and invitro.Macromolecules 1987; 20:2398–2408.
Baker R. Controlled Release of Bioactive Agents, 1980; Academic, New York.
Kuethe KO, Augustein DC, Gresser JD, and Wise DL. Design of capsules that burst at predetermined times by dialysis. JControlled Rel 1992; 18: 159–164.
Ross TF. Applied Stress Analysis,1987; Halstad Press.
Perry JH. Chemical Engineer ‘s Handbook, 1950; Mc Graw-Hill, New York.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Akiti, O., Jimoh, A.G., Wise, D.L., Barabino, G.A., Trantolo, D.J., Gresser, J.D. (1996). Multiphasic or “Pulsatile” Controlled Release System for the Delivery of Vaccines. In: Wise, D.L., Trantolo, D.J., Altobelli, D.E., Yaszemski, M.J., Gresser, J.D. (eds) Human Biomaterials Applications. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4757-2487-5_14
Download citation
DOI: https://doi.org/10.1007/978-1-4757-2487-5_14
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-012-0
Online ISBN: 978-1-4757-2487-5
eBook Packages: Springer Book Archive